Cargando…

Treatment of Extra — Abdominal Desmoid Tumors with Chemotherapy

Fibromatosis, or extra-abdominal desmoid tumor, is a benign disease which often has an aggressive clinical course that can be difficult to treat. We performed a retrospective review of 16 patients (12 females and four males) with a mean age of 34.2 years treated with methotrexate and vinblastine for...

Descripción completa

Detalles Bibliográficos
Autores principales: Montgomery, Corey, Emory, Cynthia, Adams, Sheila, Cohen, Jonathan, Pitcher, John David, Potter, Benjamin Kyle, Temple, H. Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759201/
https://www.ncbi.nlm.nih.gov/pubmed/24212959
http://dx.doi.org/10.3390/cancers3033394
_version_ 1782477222729220096
author Montgomery, Corey
Emory, Cynthia
Adams, Sheila
Cohen, Jonathan
Pitcher, John David
Potter, Benjamin Kyle
Temple, H. Thomas
author_facet Montgomery, Corey
Emory, Cynthia
Adams, Sheila
Cohen, Jonathan
Pitcher, John David
Potter, Benjamin Kyle
Temple, H. Thomas
author_sort Montgomery, Corey
collection PubMed
description Fibromatosis, or extra-abdominal desmoid tumor, is a benign disease which often has an aggressive clinical course that can be difficult to treat. We performed a retrospective review of 16 patients (12 females and four males) with a mean age of 34.2 years treated with methotrexate and vinblastine for newly diagnosed or recurrent extra-abdominal desmoid tumor. The mean age of our patient cohort was 34.2 years (range 11–70), and the mean tumor size was 11.5 cm (range 2.5–21.2 cm). The mean duration of therapy was 12 months with an average follow-up of 43 months (range 1–149 months). Fourteen of 16 patients demonstrated a clinical response to treatment. Eight of 14 patients demonstrated a radiologic decrease in tumor size. Only one patient progressed on therapy. Six patients developed recurrent symptoms after discontinuation of treatment. Chemotherapy-related symptoms including neutropenia, nausea, and vomiting were common and observed in most patients, however these side effects were mild and transient. Five patients developed peripheral neuropathy that prompted a change from vinblastine to vinorelbine during treatment. One potentially life-threatening complication (pneumocystis pneumonia) occurred which was diagnosed early and successfully treated. The use of methotrexate and vinblastine/vinorelbine in the management of fibromatosis appears to be an effective treatment with minimal treatment-related side effects.
format Online
Article
Text
id pubmed-3759201
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Molecular Diversity Preservation International (MDPI)
record_format MEDLINE/PubMed
spelling pubmed-37592012013-09-04 Treatment of Extra — Abdominal Desmoid Tumors with Chemotherapy Montgomery, Corey Emory, Cynthia Adams, Sheila Cohen, Jonathan Pitcher, John David Potter, Benjamin Kyle Temple, H. Thomas Cancers (Basel) Article Fibromatosis, or extra-abdominal desmoid tumor, is a benign disease which often has an aggressive clinical course that can be difficult to treat. We performed a retrospective review of 16 patients (12 females and four males) with a mean age of 34.2 years treated with methotrexate and vinblastine for newly diagnosed or recurrent extra-abdominal desmoid tumor. The mean age of our patient cohort was 34.2 years (range 11–70), and the mean tumor size was 11.5 cm (range 2.5–21.2 cm). The mean duration of therapy was 12 months with an average follow-up of 43 months (range 1–149 months). Fourteen of 16 patients demonstrated a clinical response to treatment. Eight of 14 patients demonstrated a radiologic decrease in tumor size. Only one patient progressed on therapy. Six patients developed recurrent symptoms after discontinuation of treatment. Chemotherapy-related symptoms including neutropenia, nausea, and vomiting were common and observed in most patients, however these side effects were mild and transient. Five patients developed peripheral neuropathy that prompted a change from vinblastine to vinorelbine during treatment. One potentially life-threatening complication (pneumocystis pneumonia) occurred which was diagnosed early and successfully treated. The use of methotrexate and vinblastine/vinorelbine in the management of fibromatosis appears to be an effective treatment with minimal treatment-related side effects. Molecular Diversity Preservation International (MDPI) 2011-08-25 /pmc/articles/PMC3759201/ /pubmed/24212959 http://dx.doi.org/10.3390/cancers3033394 Text en © 2011 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Montgomery, Corey
Emory, Cynthia
Adams, Sheila
Cohen, Jonathan
Pitcher, John David
Potter, Benjamin Kyle
Temple, H. Thomas
Treatment of Extra — Abdominal Desmoid Tumors with Chemotherapy
title Treatment of Extra — Abdominal Desmoid Tumors with Chemotherapy
title_full Treatment of Extra — Abdominal Desmoid Tumors with Chemotherapy
title_fullStr Treatment of Extra — Abdominal Desmoid Tumors with Chemotherapy
title_full_unstemmed Treatment of Extra — Abdominal Desmoid Tumors with Chemotherapy
title_short Treatment of Extra — Abdominal Desmoid Tumors with Chemotherapy
title_sort treatment of extra — abdominal desmoid tumors with chemotherapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759201/
https://www.ncbi.nlm.nih.gov/pubmed/24212959
http://dx.doi.org/10.3390/cancers3033394
work_keys_str_mv AT montgomerycorey treatmentofextraabdominaldesmoidtumorswithchemotherapy
AT emorycynthia treatmentofextraabdominaldesmoidtumorswithchemotherapy
AT adamssheila treatmentofextraabdominaldesmoidtumorswithchemotherapy
AT cohenjonathan treatmentofextraabdominaldesmoidtumorswithchemotherapy
AT pitcherjohndavid treatmentofextraabdominaldesmoidtumorswithchemotherapy
AT potterbenjaminkyle treatmentofextraabdominaldesmoidtumorswithchemotherapy
AT templehthomas treatmentofextraabdominaldesmoidtumorswithchemotherapy